Cardiac contraction-induced GLUT4 translocation requires dual signaling input

Trends in Endocrinology and Metabolism

Volumn 26, Issue 8, 2015, Pages 404-410

  Luiken, Joost J F P ^a   Glatz, Jan F C ^a   Neumann, Dietbert ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cardiac contraction; Diabetes; Glucose uptake; Heart; Signaling pathway

Indexed keywords

ABELSON KINASE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CARDIAC MYOSIN; DEATH ASSOCIATED PROTEIN KINASE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PHORBOL ESTER; PHOSPHATIDIC ACID; PHOSPHATIDYLINOSITOL 4 KINASE IIIBETA; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN KINASE C; PROTEIN KINASE D; PROTEIN KINASE D1; PROTEIN KINASE LKB1; PROTEIN TYROSINE KINASE; RAB PROTEIN; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; SECRETORY PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; AUTOPHOSPHORYLATION; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; DIASTOLIC DYSFUNCTION; ELECTROSTIMULATION; ENDOSOME; ENZYME ACTIVATION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GOLGI COMPLEX; HEART CONTRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MUSCLE CELL; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SARCOLEMMA; SECOND MESSENGER; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANS GOLGI NETWORK; TRANSPORT VESICLE; ANIMAL; CARDIAC MUSCLE; METABOLISM; PHYSIOLOGY;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; GLUCOSE TRANSPORTER TYPE 4; HUMANS; MYOCARDIUM; PROTEIN KINASE C; SIGNAL TRANSDUCTION;

EID: 84938286741     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2015.06.002     Document Type: Review

References (64)

1. Savage D.B., et al. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 2007, 87:507-520.
2. Till M., et al. Molecular mechanisms of contraction-induced translocation of GLUT4 in isolated cardiomyocytes. Am. J. Cardiol. 1997, 80:85A-89A.
3. Abel E.D. Glucose transport in the heart. Front. Biosci. 2004, 9:201-215.
4. Zorzano A., et al. Regulation of glucose transport, and glucose transporters expression and trafficking in the heart: studies in cardiac myocytes. Am. J. Cardiol. 1997, 80:65A-76A.
5. Morgan B.J., et al. GLUT4 associated proteins as therapeutic targets for diabetes. Recent Pat. Endocr. Metab. Immune Drug Discov. 2011, 5:25-32.
6. Luiken J.J., et al. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 2003, 52:1627-1634.
7. Lund S., et al. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:5817-5821.
8. Viollet B., et al. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab. 2007, 33:395-402.
9. Kurth-Kraczek E.J., et al. 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 1999, 48:1667-1671.
10. Hardie D.G. Energy sensing by the AMP-activated protein kinase and its effects on muscle metabolism. Proc. Nutr. Soc. 2011, 70:92-99.
11. Richter E.A., et al. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol. Rev. 2013, 93:993-1017.
12. Jorgensen S.B., et al. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J. Biol. Chem. 2004, 279:1070-1079.
13. Habets D.D., et al. Crucial role for LKB1 to AMPKalpha2 axis in the regulation of CD36-mediated long-chain fatty acid uptake into cardiomyocytes. Biochim. Biophys. Acta 2009, 1791:212-219.
14. Sakamoto K., et al. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J. 2005, 24:1810-1820.
15. Sakamoto K., et al. Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E780-E788.
16. Angin Y., et al. Calcium signaling recruits substrate transporters GLUT4 and CD36 to the sarcolemma without increasing cardiac substrate uptake. Am. J. Physiol. Endocrinol. Metab. 2014, 307:E225-E236.
17. Alessi D.R., et al. LKB1-dependent signaling pathways. Annu. Rev. Biochem. 2006, 75:137-163.
18. Neumann D., et al. Co-expression of LKB1, MO25alpha and STRADalpha in bacteria yield the functional and active heterotrimeric complex. Mol. Biotechnol. 2007, 36:220-231.
19. Cartee G.D. Roles of TBC1D1 and TBC1D4 in insulin- and exercise-stimulated glucose transport of skeletal muscle. Diabetologia 2015, 58:19-30.
20. Chen S., et al. Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking. Cell Metab. 2011, 13:68-79.
21. Peck G.R., et al. Interaction of the Akt substrate, AS160, with the glucose transporter 4 vesicle marker protein, insulin-regulated aminopeptidase. Mol. Endocrinol. 2006, 20:2576-2583.
22. Ramm G., et al. A role for 14-3-3 in insulin-stimulated GLUT4 translocation through its interaction with the RabGAP AS160. J. Biol. Chem. 2006, 281:29174-29180.
23. Kramer H.F., et al. AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle. J. Biol. Chem. 2006, 281:31478-31485.
24. Ducommun S., et al. Thr649Ala-AS160 knock-in mutation does not impair contraction/AICAR-induced glucose transport in mouse muscle. Am. J. Physiol. Endocrinol. Metab. 2012, 302:E1036-E1043.
25. Taylor E.B., et al. Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle. J. Biol. Chem. 2008, 283:9787-9796.
26. Lee M.T., et al. Structural mechanisms for regulation of membrane traffic by rab GTPases. Traffic 2009, 10:1377-1389.
27. Fukuda M. TBC proteins: GAPs for mammalian small GTPase Rab?. Biosci. Rep. 2011, 31:159-168.
28. Ishikura S., et al. Muscle cells engage Rab8A and myosin Vb in insulin-dependent GLUT4 translocation. Am. J. Physiol. Cell Physiol. 2008, 295:C1016-C1025.
29. Sadacca L.A., et al. Specialized sorting of GLUT4 and its recruitment to the cell surface are independently regulated by distinct Rabs. Mol. Biol. Cell 2013, 24:2544-2557.
30. Cleland P.J., et al. Exercise-induced translocation of protein kinase C and production of diacylglycerol and phosphatidic acid in rat skeletal muscle in vivo. Relationship to changes in glucose transport. J. Biol. Chem. 1989, 264:17704-17711.
31. Rozengurt E. Protein kinase D signaling: multiple biological functions in health and disease. Physiology (Bethesda) 2011, 26:23-33.
32. Hausser A., et al. Protein kinase D regulates vesicular transport by phosphorylating and activating phosphatidylinositol-4 kinase IIIbeta at the Golgi complex. Nat. Cell Biol. 2005, 7:880-886.
33. Storz P. Mitochondrial ROS: radical detoxification, mediated by protein kinase D. Trends Cell Biol. 2007, 17:13-18.
34. Dirkx E., et al. Protein kinase D1 is essential for contraction-induced glucose uptake but is not involved in fatty acid uptake into cardiomyocytes. J. Biol. Chem. 2012, 287:5871-5881.
35. Luiken J.J., et al. Identification of protein kinase D as a novel contraction-activated kinase linked to GLUT4-mediated glucose uptake, independent of AMPK. Cell. Signal. 2008, 20:543-556.
36. Steinbusch L.K., et al. Overexpression of AMP-activated protein kinase or protein kinase D prevents lipid-induced insulin resistance in cardiomyocytes. J. Mol. Cell. Cardiol. 2013, 55:165-173.
37. Dirkx E., et al. Protein kinase-D1 overexpression prevents lipid-induced cardiac insulin resistance. J. Mol. Cell. Cardiol. 2014, 76:208-217.
38. Gruenberg J., et al. Membrane transport in the endocytic pathway. Curr. Opin. Cell Biol. 1995, 7:552-563.
39. Dirkx E., et al. Detection of cardiac myosin binding protein-C (cMyBP-C) by a phospho-specific PKD antibody in contracting rat cardiomyocytes. Adv. Biosci. Biotechnol. 2013, 4:1-6.
40. Eisenberg-Lerner A., et al. DAP kinase regulates JNK signaling by binding and activating protein kinase D under oxidative stress. Cell Death Differ. 2007, 14:1908-1915.
41. Eisenberg-Lerner A., et al. PKD is a kinase of Vps34 that mediates ROS-induced autophagy downstream of DAPk. Cell Death Differ. 2012, 19:788-797.
42. Ghanekar Y., et al. Signalling for secretion. Nat. Cell Biol. 2005, 7:851-853.
43. Valente C., et al. Purification and functional properties of the membrane fissioning protein CtBP3/BARS. Methods Enzymol. 2005, 404:296-316.
44. Horman S., et al. AMP-activated protein kinase phosphorylates and desensitizes smooth muscle myosin light chain kinase. J. Biol. Chem. 2008, 283:18505-18512.
45. Banko M.R., et al. Chemical genetic screen for AMPKalpha2 substrates uncovers a network of proteins involved in mitosis. Mol. Cell 2011, 44:878-892.
46. Chen S., et al. Alpha1 catalytic subunit of AMPK modulates contractile function of cardiomyocytes through phosphorylation of troponin I. Life Sci. 2014, 98:75-82.
47. Nixon B.R., et al. AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function. J. Biol. Chem. 2012, 287:19136-19147.
48. 2+ sensitivity and cross-bridge cycling. J. Biol. Chem. 2010, 285:5674-5682.
49. Haworth R.S., et al. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ. Res. 2004, 95:1091-1099.
50. 2+-activated tension of cardiomyocyte contraction by phosphorylation of cMyBP-C-Ser315. Am. J. Physiol. Heart Circ. Physiol. 2012, 303:H323-H331.
51. Gupte A., et al. Activation of the Cbl insulin signaling pathway in cardiac muscle; dysregulation in obesity and diabetes. Biochem. Biophys. Res. Commun. 2006, 342:751-757.
52. Kanzaki M. Insulin receptor signals regulating GLUT4 translocation and actin dynamics. Endocr. J. 2006, 53:267-293.
53. Saltiel A.R., et al. Insulin signaling in microdomains of the plasma membrane. Traffic 2003, 4:711-716.
54. Zhou Q.L., et al. Analysis of insulin signalling by RNAi-based gene silencing. Biochem. Soc. Trans. 2004, 32:817-821.
55. Sylow L., et al. Rac1 signaling is required for insulin-stimulated glucose uptake and is dysregulated in insulin-resistant murine and human skeletal muscle. Diabetes 2013, 62:1865-1875.
56. Sylow L., et al. Stretch-stimulated glucose transport in skeletal muscle is regulated by Rac1. J. Physiol. 2015, 593:645-656.
57. Boudina S., et al. Diabetic cardiomyopathy, causes and effects. Rev. Endocr. Metab. Disord. 2010, 11:31-39.
58. Harmancey R., et al. The complexities of diabetic cardiomyopathy: lessons from patients and animal models. Curr. Diab. Rep. 2008, 8:243-248.
59. Dirkx E., et al. High fat diet induced diabetic cardiomyopathy. Prostaglandins Leukot. Essent. Fatty Acids 2011, 85:219-225.
60. Harrison B.C., et al. Regulation of cardiac stress signaling by protein kinase d1. Mol. Cell. Biol. 2006, 26:3875-3888.
61. Merrill G.F., et al. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 1997, 273:E1107-E1112.
62. Abbott M.J., et al. CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 297:R1724-R1732.
63. Mahon A.D., et al. Evaluating the prediction of maximal heart rate in children and adolescents. Res. Q. Exerc. Sport 2010, 81:466-471.
64. Coven D.L., et al. Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E629-E636.